Litcius/Paper detail

Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19

Xueting Li, Mi-Wen Zhang, Zhen-Zhou Zhang, Yudan Cao, Xiaoyan Liu, Ran Miao, Yuan Xu, Xiao-Fang Song, Jia-Wei Song, Ying Liu, Ying‐Le Xu, Jing Li, Ying Dong, Jiuchang Zhong

2021International Journal of Cardiology27 citationsDOIOpen Access PDF

Topics & Concepts

ApelinMedicineCardiorenal syndromeDownregulation and upregulationAngiotensin-converting enzyme 2Proinflammatory cytokineInflammationInternal medicineEndocrinologyKidneyReceptorCoronavirus disease 2019 (COVID-19)BiologyDiseaseInfectious disease (medical specialty)GeneBiochemistryApelin-related biomedical researchCardiovascular, Neuropeptides, and Oxidative Stress ResearchLipid metabolism and disorders
Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19 | Litcius